Financial Documentation
Financial Information
2022 First half financial results communication
Year-end 2021 financial results and corporate structure report
Annual Report 2021
BME Growth Communications
Information regarding acquisitions
Information regarding acquisition
Information regarding Sngular’s acquisition of Corunet.
Other relevant information
Major shareholders
Notice of operations by Sngular executives
Integration of Belike
Notice of relevant facts
Major shareholders
Parenclitic- Sngular Holder Absorption Fusion
Transactions completed by Parenclitic
Notice of operations by Sngular executives
Notice of operations by Sngular executives
Transactions completed by Parenclitic
Changes in the Board of Directors
Transactions completed by Parenclitic
Transactions completed by Parenclitic
Integration of Atlera
Transactions completed by Parenclitic
Stock buyback program
Major shareholders
Transactions completed by Parenclitic
Transactions completed by Parenclitic
Major shareholders
Stock buyback program
Stock buyback program
Notice of operations by Sngular executives
Resolutions adopted at the Ordinary General Shareholders' Meeting
Medcap 2022 Forum Presentation
2022 Ordinary General Shareholders' Meeting Presentation
Notice of Ordinary General Shareholders Meeting
Communication operations administrator subsidiary Group Sngular
Notice of operations by Sngular executives
Purchase and sale by Sngular executives and updated major
Notice of operations by Sngular executives
Notice of operations by Sngular executives
Integration of Acilia
Major shareholders
Major shareholders
Notice of relevant facts
Costs of IPO